The U.S. Oncology Information Systems Market was valued at USD 900.29 Million in 2024, and is projected to reach USD 1.38 Billion by 2030, rising at a CAGR of 7.40%. The growing prevalence of cancer among various demographics and the rising demand for advanced innovative oncology information systems (OIS) are some of the driving factors for the U.S. oncology information systems industry. Oncology information solutions deployment is high in hospitals & cancer research institutes in the U.S. due to the rise in the prevalence of cancer and the increase in healthcare expenditure budget.
The U.S. OIS industry is poised for significant growth, driven by the rising cancer burden and the increasing integration of advanced healthcare IT solutions. According to the National Cancer Institute, over 2 million new cancer cases are projected to be diagnosed in the U.S. in 2024, with an estimated 611,720 cancer-related deaths. This escalating disease incidence necessitates robust data management and clinical decision support systems, thereby accelerating the demand for OIS platforms across healthcare facilities.
Moreover, the healthcare sector in the U.S. has witnessed a surge in the adoption of digital technologies aimed at optimizing workflows, administrative functions, and patient care delivery. Oncology information systems, equipped with advanced functionalities such as treatment planning, data visualization, and patient tracking, have emerged as critical tools for improving clinical outcomes and operational efficiency.
Furthermore, increased investment in oncology R&D, supported by both public and private organizations, is fostering product innovation. For instance, the American Brachytherapy Society (ABS), a prominent nonprofit founded in 1978, actively supports the advancement of brachytherapy through professional education, research promotion, and awareness-building initiatives. Such organizations play a pivotal role in driving innovation and knowledge dissemination in oncology care.
In addition, the growing integration of artificial intelligence (AI) into oncology workflows is expected to further propel market expansion. In October 2024, Ontada, a McKesson Corporation subsidiary, partnered with Microsoft to utilize Azure AI, including Azure OpenAI Service, to enhance the processing of unstructured oncology data. This collaboration aims to extract actionable insights from complex clinical documents, ultimately supporting data-driven treatment planning and real-time decision-making.
This product will be delivered within 1-3 business days.
The U.S. OIS industry is poised for significant growth, driven by the rising cancer burden and the increasing integration of advanced healthcare IT solutions. According to the National Cancer Institute, over 2 million new cancer cases are projected to be diagnosed in the U.S. in 2024, with an estimated 611,720 cancer-related deaths. This escalating disease incidence necessitates robust data management and clinical decision support systems, thereby accelerating the demand for OIS platforms across healthcare facilities.
Moreover, the healthcare sector in the U.S. has witnessed a surge in the adoption of digital technologies aimed at optimizing workflows, administrative functions, and patient care delivery. Oncology information systems, equipped with advanced functionalities such as treatment planning, data visualization, and patient tracking, have emerged as critical tools for improving clinical outcomes and operational efficiency.
Furthermore, increased investment in oncology R&D, supported by both public and private organizations, is fostering product innovation. For instance, the American Brachytherapy Society (ABS), a prominent nonprofit founded in 1978, actively supports the advancement of brachytherapy through professional education, research promotion, and awareness-building initiatives. Such organizations play a pivotal role in driving innovation and knowledge dissemination in oncology care.
In addition, the growing integration of artificial intelligence (AI) into oncology workflows is expected to further propel market expansion. In October 2024, Ontada, a McKesson Corporation subsidiary, partnered with Microsoft to utilize Azure AI, including Azure OpenAI Service, to enhance the processing of unstructured oncology data. This collaboration aims to extract actionable insights from complex clinical documents, ultimately supporting data-driven treatment planning and real-time decision-making.
U.S. Oncology Information Systems Market Report: Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the U.S. oncology information systems market report based on products & services, application, and end use:Products & Services Outlook (Revenue, USD Million, 2018-2030)
- Software
- Professional Services
Application Outlook (Revenue, USD Million, 2018-2030)
- Medical Oncology
- Radiation Oncology
- Surgical Oncology
End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals & Diagnostic Imaging Centers
- Ablation Care Centers and Cancer Care Centers
- Government Institutions
- Research Facilities
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Oncology Information Systems Market Variables, Trends & Scope
Chapter 4. U.S. Oncology Information Systems Market: Products & Services Estimates & Trend Analysis
Chapter 5. U.S. Oncology Information Systems Market: Application Estimates & Trend Analysis
Chapter 6. U.S. Oncology Information Systems Market: End Use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The companies profiled in this U.S. Oncology Information Systems market report include:- Elekta AB
- Accuray Incorporated
- Varian Medical Systems (Siemens Healthineers)
- RaySearch Laboratories
- Cerner Corporation (Oracle Corporation)
- BrainLab
- Philips Healthcare
- Prowess, Inc.
- DOSIsoft S.A.
- ViewRay Inc.
- MIM Software
- Flatiron
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 900.29 Million |
| Forecasted Market Value ( USD | $ 1380 Million |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | United States |
| No. of Companies Mentioned | 13 |
